SCHEMBL691573

SCHEMBL691573

CCCn1nc(C)cc1Nc1cc(Nc2cc(F)ccc2C(=O)O)c(Cl)cn1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.50
MAPK3 P27361 1/20 0.50
PTK2 Q05397 1/20 0.44
KDM4C Q9H3R0 7/20 0.43
CLCN2 P51788 1/20 0.42
RPS6KA1 Q15418 1/20 0.37
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GAA P10253 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
FTO Q9C0B1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL691390 0.93 PTK2 (0.46) MAPK1MAPK3PTK2KDM4CRPS6KA1
SCHEMBL689985 0.91 PTK2 (0.45) MAPK1MAPK3PTK2KDM4CMEN1
SCHEMBL690575 0.89 PTK2 (0.58) MAPK1MAPK3PTK2KDM4CRPS6KA1
SCHEMBL691296 0.88 PTK2 (0.56) MAPK1MAPK3PTK2KDM4CCLCN2
SCHEMBL691084 0.85 PTK2 (0.47) MAPK1MAPK3PTK2KDM4CPOLB
SCHEMBL691211 0.84 PTK2 (0.44) MAPK1MAPK3PTK2KDM4CCLCN2
SCHEMBL1293001 0.84 MAPK1 (0.61) MAPK1MAPK3PTK2RPS6KA1
SCHEMBL692012 0.84 PTK2 (0.58) MAPK1MAPK3PTK2KDM4CRPS6KA1
SCHEMBL691572 0.84 PTK2 (0.62) MAPK1MAPK3PTK2KDM4CCLCN2
SCHEMBL1292976 0.82 PTK2 (0.60) MAPK1MAPK3PTK2RPS6KA1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421537-A1 PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK GlaxoSmithKline LLC (US) 2012-02-29 EP disclosed
WO-2010062578-A1 PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK GLAXOSMITHKLINE LLC (US) 2010-06-03 WO disclosed